Pacific Biosciences of California, Inc.

PACB
As of the close on Sep 25, 2026
Price
$1.62
Market cap
$504M
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Pacific Biosciences of California, Inc. Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Pacific Biosciences of California, Inc. — 10-Q filed Aug 6, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 4, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
Cassaday & Co Wealth Management LLC 2026-03-31 380 $502 SEC filing
Engineers Gate Manager LP 2026-03-31 52,289 $69K SEC filing
Point72 Asset Management, L.P. 2026-03-31 285,700 $377K SEC filing
Hudson Bay Capital Management LP 2026-03-31 14,300 $18.9K SEC filing
XPONANCE LLC 2026-03-31 24,777 $32.7K SEC filing
RHUMBLINE ADVISERS 2026-03-31 348,942 $461K SEC filing
BARCLAYS PLC 2026-03-31 222,347 $293K SEC filing
Kingsview Wealth Management, LLC 2026-03-31 10,765 $14.2K SEC filing
Abel Hall, LLC 2026-03-31 22,699 $30K SEC filing
Amova Asset Management Americas, Inc. 2026-03-31 7,037,987 $9.22M SEC filing
Bank of New York Mellon Corp 2026-03-31 813,406 $1.07M SEC filing
CIBC WORLD MARKET INC. 2026-03-31 11,400 $15K SEC filing
JONES FINANCIAL COMPANIES LLLP 2026-03-31 1,000 $1.26K SEC filing
Medallion Wealth Advisors, LLC 2026-03-31 100 $132 SEC filing
BENJAMIN EDWARDS INC 2026-03-31 115,549 $152K SEC filing
Quadrature Capital Ltd 2026-03-31 112,503 $149K SEC filing
Abacus Wealth Partners, LLC 2026-03-31 18,407 $24.3K SEC filing
DEUTSCHE BANK AG\ 2026-03-31 244,769 $323K SEC filing
WATER ISLAND CAPITAL LLC 2026-03-31 272,040 $359K SEC filing
HRT FINANCIAL LP 2026-03-31 1,265,535 Not shown SEC filing
  • Each value is checked against Pacific Biosciences of California, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
  • Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Pacific Biosciences of California, Inc.'s share price.

120 filers have only one report here.

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-04-01Gibson James R II · See RemarksCommon StockS — Open market or private sale−88,1851.37SEC filing
2026-03-03Farmer Michele · See RemarksCommon StockS — Open market or private sale−2,9791.51SEC filing
2026-03-03Van Oene Mark · See RemarksCommon StockS — Open market or private sale−6,5041.51SEC filing
2026-03-03HENRY CHRISTIAN O · See RemarksCommon StockS — Open market or private sale−12,4971.51SEC filing
2026-02-18HENRY CHRISTIAN O · See RemarksCommon StockS — Open market or private sale−140,8741.63SEC filing
2026-02-18Van Oene Mark · See RemarksCommon StockS — Open market or private sale−55,1071.63SEC filing
2026-02-18Farmer Michele · See RemarksCommon StockS — Open market or private sale−14,9521.63SEC filing
2026-02-17Van Oene Mark · See RemarksCommon StockS — Open market or private sale−129,7901.58SEC filing

Showing 8 of 11 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-06-03Valantine Hannah · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+223,492SEC filing
2026-06-03MILLIGAN JOHN F · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+223,492SEC filing
2026-06-03Ericson William W. · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+223,492SEC filing
2026-06-03Gibson Christopher · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+74,497SEC filing
2026-06-03LIVINGSTON RANDALL S · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+223,492SEC filing
2026-06-03Smith Christopher M · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+223,492SEC filing
2026-06-03MOHR MARSHALL · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+223,492SEC filing
2026-06-03ORDONEZ KATHY · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+223,492SEC filing

Showing 8 of 20 rows

Other activity

SecurityCodeFiling
2022-03-17Ericson William W. · DirectorCommon StockJ — Other acquisition or disposition+1,268SEC filing
2022-03-17Ericson William W. · DirectorCommon StockJ — Other acquisition or disposition−4,848,397SEC filing
2021-02-12Ericson William W. · DirectorCommon StockJ — Other acquisition or disposition−750,000SEC filing
2021-02-12Ericson William W. · DirectorCommon StockJ — Other acquisition or disposition+68SEC filing

Showing 4 of 4 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.